- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02899520
Evaluation of Programs of Reeducation for Urinary Incontinence in Woman (ReedPerinee)
December 31, 2019 updated by: Hopital Foch
The objective of this study is to compare two methods of pelvic floor muscle training: reference method versus CMP ® method ( (Connaissance et Maîtrise de Périnée : Knowledge and Control of Perineum)
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Suresnes, France, 92150
- Hôpital Foch
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Patients more than 18 years old and less than 75 years
- Patients presenting an urinary incontinence of effort or mixed symptomatic associated with a pelvic statics disorder
- Patients with a perineale reeducation prescription
- Patients affiliated to a national insurance scheme or benefiting from such a program
- Patients having given her written consent form
Exclusion Criteria:
- Nulliparous woman
- Patients already operated for their incontinence
- Patients with a prolapse of higher level at the stage II of the classification POP-Q (Pelvic Organ Prolapse Quantification)
- Pregnant women
- Patients presenting an associated anal incontinence,
- Patients presenting a cancellation (section of marrow, syringomyelia for example) or an inversion of perineum control
- Patients having given birth less than 6 months before the care
- Patients having benefited from a pelvi-périnéale reeducation in the previous 12 months,
- Patients presenting psychiatric disease
- Patients presenting a vaginismus,
- Patients presenting a contraindication to the practice of the electrostimulation.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Group A
Reference method
|
Electrostimulation associated to perineal training
|
Experimental: Group B
CMP ® method (Knowledge and Control of Perineum)
|
Method based on Knowledge and Control of Perineum
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
USP (Urinary Symptoms Profile) score
Time Frame: 38 weeks
|
Urinary Symptoms Profile score
|
38 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Sophie FLANDIN-CRETINON, Hôpital Foch
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 10, 2014
Primary Completion (Actual)
October 18, 2019
Study Completion (Actual)
October 18, 2019
Study Registration Dates
First Submitted
September 9, 2016
First Submitted That Met QC Criteria
September 9, 2016
First Posted (Estimate)
September 14, 2016
Study Record Updates
Last Update Posted (Actual)
January 3, 2020
Last Update Submitted That Met QC Criteria
December 31, 2019
Last Verified
December 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2014/09
- 2014-A00709-38 (Other Identifier: ANSM)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Urinary Incontinence
-
University of New MexicoRecruitingUrinary Incontinence | Urge Incontinence | Stress Incontinence, FemaleUnited States
-
Juna d.o.o.CompletedFemale Stress Urinary Incontinence | Mixed Incontinence, Urge and Stress
-
University of California, San FranciscoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Stanford...CompletedUrinary Incontinence, Stress | Urge Incontinence | Urinary Stress Incontinence | Stress Incontinence, Urinary | Stress Incontinence | Stress Incontinence, Female | Urgency UrinaryUnited States
-
Ludwig-Maximilians - University of MunichUnknownIncontinence, Overactive Bladder, Stress Urinary IncontinenceGermany
-
San Diego Sexual MedicineRecruitingStress Urinary Incontinence | Urge IncontinenceUnited States
-
Far Eastern Memorial HospitalRecruitingWomen With Stress Urinary IncontinenceTaiwan
-
Copenhagen University Hospital at HerlevZealand University HospitalTerminatedStress Urinary Incontinence | Urge Urinary IncontinenceDenmark
-
ScitonCompletedUrinary Incontinence | Stress Urinary Incontinence | Urge IncontinenceUnited States
-
Université de SherbrookeRecruitingUrinary Incontinence | Urinary Stress Incontinence | Post-Prostatectomy Incontinence | Stress Incontinence, MaleCanada
-
University of ZurichCompletedStress Urinary Incontinence | Urge Urinary Incontinence
Clinical Trials on Reference method
-
Meridian Bioscience, Inc.CompletedClostridium Difficile InfectionUnited States, Canada
-
Meridian Bioscience, Inc.CompletedPharyngitis, InfectiveUnited States, Canada
-
Meridian Bioscience, Inc.CompletedStreptococcus Agalactiae InfectionCanada, United States
-
Institut fur Diabetes Karlsburg GmbHAktivmed GmbH; Beurer GmbH; IME-DC GmbH; Medisana GmbHCompleted
-
Johan Siebert, MDGeneva Children's Hospital, Geneva, Switzerland; Alberta Children's Hospital...Not yet recruitingPediatric | Resuscitation | Cardiopulmonary ArrestSwitzerland, Canada
-
Hvidovre University HospitalOdense University Hospital; Aarhus University Hospital; Rigshospitalet, Denmark; Aalborg University Hospital and other collaboratorsCompletedSARS-CoV2 Infection | COVID-19 TestingDenmark
-
Centre Hospitalier Universitaire, AmiensCompletedCardiac Output | PeroperativeFrance
-
Foundation for Innovative New Diagnostics, SwitzerlandUniversity Hospital, Geneva; B.P. Koirala Institute of Health SciencesCompletedDiabetes Mellitus | Chronic Kidney Diseases | HyperlipidemiasNepal
-
The Affiliated Hospital of Qingdao UniversityEnrolling by invitationPharmacokinetics | SafetyChina
-
Hospices Civils de LyonRecruitingAcute Respiratory Distress SyndromeFrance